Unapproved clinical trials in Russia: exception or norm?

Petr Talantov, Ravil Niyazov, Galina Viryasova, Margarita Dranitsyna, Ilya Yasny

Open source

DOI
10.1186/s12910-021-00617-3
Published
2021-04-20
Container
BMC Medical Ethics
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12910-021-00617-3,
  title = {Unapproved clinical trials in Russia: exception or norm?},
  author = {Petr Talantov and Ravil Niyazov and Galina Viryasova and Margarita Dranitsyna and Ilya Yasny},
  year = {2021},
  journal = {BMC Medical Ethics},
  doi = {10.1186/s12910-021-00617-3},
  url = {https://doi.org/10.1186/s12910-021-00617-3}
}

RIS

TY  - JOUR
TI  - Unapproved clinical trials in Russia: exception or norm?
AU  - Petr Talantov
AU  - Ravil Niyazov
AU  - Galina Viryasova
AU  - Margarita Dranitsyna
AU  - Ilya Yasny
PY  - 2021
JO  - BMC Medical Ethics
DO  - 10.1186/s12910-021-00617-3
UR  - https://doi.org/10.1186/s12910-021-00617-3
ER  - 

APA

Talantov, P., Niyazov, R., Viryasova, G., Dranitsyna, M., & Yasny, I. (2021). Unapproved clinical trials in Russia: exception or norm?. BMC Medical Ethics. https://doi.org/10.1186/s12910-021-00617-3

Source records